257 related articles for article (PubMed ID: 25710962)
1. Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.
Ager EI; Kozin SV; Kirkpatrick ND; Seano G; Kodack DP; Askoxylakis V; Huang Y; Goel S; Snuderl M; Muzikansky A; Finkelstein DM; Dransfield DT; Devy L; Boucher Y; Fukumura D; Jain RK
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25710962
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.
Fahey JM; Girotti AW
Nitric Oxide; 2017 Jan; 62():52-61. PubMed ID: 28007662
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor.
Thomsen LL; Scott JM; Topley P; Knowles RG; Keerie AJ; Frend AJ
Cancer Res; 1997 Aug; 57(15):3300-4. PubMed ID: 9242464
[TBL] [Abstract][Full Text] [Related]
4. Effects of inducible nitric oxide synthase inhibition in bronchial vascular remodeling-induced by chronic allergic pulmonary inflammation.
Prado CM; Yano L; Rocha G; Starling CM; Capelozzi VL; Leick-Maldonado EA; Martins Mde A; Tibério IF
Exp Lung Res; 2011 Jun; 37(5):259-68. PubMed ID: 21585312
[TBL] [Abstract][Full Text] [Related]
5. Selective iNOS inhibitor 1400W enhances anti-catabolic IL-10 and reduces destructive MMP-10 in OA cartilage. Survey of the effects of 1400W on inflammatory mediators produced by OA cartilage as detected by protein antibody array.
Järvinen K; Vuolteenaho K; Nieminen R; Moilanen T; Knowles RG; Moilanen E
Clin Exp Rheumatol; 2008; 26(2):275-82. PubMed ID: 18565249
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
[TBL] [Abstract][Full Text] [Related]
7. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways.
Sugiyama Y; Kakoi K; Kimura A; Takada I; Kashiwagi I; Wakabayashi Y; Morita R; Nomura M; Yoshimura A
Int Immunol; 2012 Apr; 24(4):253-65. PubMed ID: 22331441
[TBL] [Abstract][Full Text] [Related]
8. Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages.
Vicente AM; Guillén MI; Alcaraz MJ
Br J Pharmacol; 2001 Jul; 133(6):920-6. PubMed ID: 11454666
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration.
Xu J; Luo Y; Yuan C; Han L; Wu Q; Xu L; Gao Y; Sun Y; Ma S; Tang G; Li S; Sun W; Gong Y; Xie C
Int J Biol Sci; 2020; 16(9):1563-1574. PubMed ID: 32226302
[TBL] [Abstract][Full Text] [Related]
10. Systemic use of selective iNOS inhibitor 1400W or non-selective NOS inhibitor l-NAME differently affects systemic nitric oxide formation after oral Porphyromonas gingivalis inoculation in mice.
Nemec A; Pavlica Z; Petelin M; Crossley DA; Sentjurc M; Jerin A; Erzen D; Zdovc I; Hitti T; Skaleric U
Arch Oral Biol; 2010 Jul; 55(7):509-14. PubMed ID: 20430367
[TBL] [Abstract][Full Text] [Related]
11. Selective iNOS inhibition reduces renal damage induced by cisplatin.
Chirino YI; Trujillo J; Sánchez-González DJ; Martínez-Martínez CM; Cruz C; Bobadilla NA; Pedraza-Chaverri J
Toxicol Lett; 2008 Jan; 176(1):48-57. PubMed ID: 18063323
[TBL] [Abstract][Full Text] [Related]
12. Role of inducible nitric oxide synthase expressed by alveolar macrophages in high mobility group box 1--induced acute lung injury.
Ren D; Sun R; Wang S
Inflamm Res; 2006 May; 55(5):207-15. PubMed ID: 16830108
[TBL] [Abstract][Full Text] [Related]
13. Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression.
Goel S; Gupta N; Walcott BP; Snuderl M; Kesler CT; Kirkpatrick ND; Heishi T; Huang Y; Martin JD; Ager E; Samuel R; Wang S; Yazbek J; Vakoc BJ; Peterson RT; Padera TP; Duda DG; Fukumura D; Jain RK
J Natl Cancer Inst; 2013 Aug; 105(16):1188-201. PubMed ID: 23899555
[TBL] [Abstract][Full Text] [Related]
14. iNOS-derived nitric oxide mediates the increase in TFF2 expression associated with gastric damage: role of HIF-1.
Ortiz-Masiá D; Hernández C; Quintana E; Velázquez M; Cebrián S; Riaño A; Calatayud S; Esplugues JV; Barrachina MD
FASEB J; 2010 Jan; 24(1):136-45. PubMed ID: 19741170
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide produced by inducible nitric oxide synthase is associated with mammary tumorigenesis in irradiated rats.
Inano H; Onoda M
Nitric Oxide; 2005 Feb; 12(1):15-20. PubMed ID: 15631943
[TBL] [Abstract][Full Text] [Related]
16. Tumoricidal activity of high-dose tumor necrosis factor-alpha is mediated by macrophage-derived nitric oxide burst and permanent blood flow shutdown.
Menon C; Bauer TW; Kelley ST; Raz DJ; Bleier JI; Patel K; Steele K; Prabakaran I; Shifrin A; Buerk DG; Sehgal CM; Fraker DL
Int J Cancer; 2008 Jul; 123(2):464-475. PubMed ID: 18449880
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory and antitumoural effects of Uncaria guianensis bark.
Urdanibia I; Michelangeli F; Ruiz MC; Milano B; Taylor P
J Ethnopharmacol; 2013 Dec; 150(3):1154-62. PubMed ID: 24212077
[TBL] [Abstract][Full Text] [Related]
18. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.
Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A
J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314
[TBL] [Abstract][Full Text] [Related]
19. Hindlimb ischemia/reperfusion-induced remote injury to the small intestine: role of inducible nitric-oxide synthase-derived nitric oxide.
Katada K; Bihari A; Badhwar A; Yoshida N; Yoshikawa T; Potter RF; Cepinskas G
J Pharmacol Exp Ther; 2009 Jun; 329(3):919-27. PubMed ID: 19270191
[TBL] [Abstract][Full Text] [Related]
20. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine.
Kankuri E; Vaali K; Knowles RG; Lähde M; Korpela R; Vapaatalo H; Moilanen E
J Pharmacol Exp Ther; 2001 Sep; 298(3):1128-32. PubMed ID: 11504810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
